• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌与饮食调整:借助肠道微生物群应对幽门螺杆菌的整体方法。

Probiotics and Diet Modifications: A Holistic Approach to Tackling Helicobacter pylori with the Help of the Gut Microbiota.

作者信息

Addissouky Tamer A, Wang Yuliang, Sayed Ibrahim El Tantawy El, Naser Naser A, Jalal AlAhmed Mohammed

机构信息

Department of Biochemistry, Science Faculty, AL-Mustaqbal University, 51001, Hillah, Babylon, Iraq.

Biochemistry Branch, Department of Chemistry, Science Faculty, Menoufia University, Menoufia, Egypt.

出版信息

Probiotics Antimicrob Proteins. 2025 Aug 12. doi: 10.1007/s12602-025-10706-z.

DOI:10.1007/s12602-025-10706-z
PMID:40794147
Abstract

BACKGROUND

Helicobacter pylori (H. pylori) is a common gastrointestinal pathogen that can persist for decades and lead to diseases like gastritis, peptic ulcers, and gastric cancer. Conventional antibiotic treatments have limitations like resistance and side effects, requiring alternative therapies. The gut microbiota may influence H. pylori colonization and eradication success. Strategies like probiotics, prebiotics, diet, and lifestyle changes may modulate the gut microbiota composition and function to inhibit H. pylori growth. Specific probiotic strains produce antimicrobial compounds, modulate immune responses, and alter gut microbiota in ways that can promote H. pylori eradication. Diets high in fiber, polyphenols, omega-3s, and fermented foods appear to inhibit H. pylori by supporting growth of beneficial bacteria. Lifestyle factors like stress, smoking, and alcohol negatively impact the gut microbiota. Personalized therapies based on the gut microbiome could optimize eradication rates.

CONCLUSION

The gut microbiota represents a promising target for enhancing H. pylori eradication. Further research on microbiota-modulating therapies like probiotics, diet, and lifestyle changes may help develop more effective, personalized treatment approaches.

摘要

背景

幽门螺杆菌是一种常见的胃肠道病原体,可长期存在数十年,并导致胃炎、消化性溃疡和胃癌等疾病。传统抗生素治疗存在耐药性和副作用等局限性,需要替代疗法。肠道微生物群可能影响幽门螺杆菌的定植和根除成功率。益生菌、益生元、饮食和生活方式改变等策略可能调节肠道微生物群的组成和功能,以抑制幽门螺杆菌生长。特定的益生菌菌株会产生抗菌化合物、调节免疫反应,并以促进幽门螺杆菌根除的方式改变肠道微生物群。富含纤维、多酚、ω-3脂肪酸和发酵食品的饮食似乎通过支持有益细菌的生长来抑制幽门螺杆菌。压力、吸烟和饮酒等生活方式因素会对肠道微生物群产生负面影响。基于肠道微生物组的个性化疗法可以优化根除率。

结论

肠道微生物群是提高幽门螺杆菌根除率的一个有前景的靶点。对益生菌、饮食和生活方式改变等微生物群调节疗法的进一步研究可能有助于开发更有效、个性化的治疗方法。

相似文献

1
Probiotics and Diet Modifications: A Holistic Approach to Tackling Helicobacter pylori with the Help of the Gut Microbiota.益生菌与饮食调整:借助肠道微生物群应对幽门螺杆菌的整体方法。
Probiotics Antimicrob Proteins. 2025 Aug 12. doi: 10.1007/s12602-025-10706-z.
2
The impact of infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis.感染与根除疗法对肠道微生物群的影响:微生物失调及其在胃癌发生中的意义的系统评价
Front Cell Infect Microbiol. 2025 Jul 7;15:1592977. doi: 10.3389/fcimb.2025.1592977. eCollection 2025.
3
Efficacy of probiotics pretreatment in eradication therapy: a systematic review and meta-analysis of clinical outcomes.益生菌预处理在根除治疗中的疗效:临床结局的系统评价和荟萃分析
Ann Med. 2025 Dec;57(1):2533431. doi: 10.1080/07853890.2025.2533431. Epub 2025 Jul 23.
4
Differential modulation of post-antibiotic colonization resistance to by two probiotic strains.两种益生菌菌株对抗生素后定植抗性的差异调节
mBio. 2025 Jul 21:e0146825. doi: 10.1128/mbio.01468-25.
5
The Ideal Helicobacter pylori Treatment for the Present and the Future.理想的幽门螺杆菌治疗方法:现状与未来。
Digestion. 2022;103(1):62-68. doi: 10.1159/000519413. Epub 2021 Oct 18.
6
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
7
The role of probiotic supplementation in reducing recurrence after classic quadruple therapy.补充益生菌在降低经典四联疗法后复发率方面的作用。
Front Pharmacol. 2025 Jul 14;16:1621090. doi: 10.3389/fphar.2025.1621090. eCollection 2025.
8
Lactiplantibacillus plantarum MH-301 reduces Helicobacter pylori treatment-related adverse events via gut-vaginal axis: A randomized, double-blind, placebo-controlled trial.植物乳杆菌MH-301通过肠-阴道轴减少幽门螺杆菌治疗相关不良事件:一项随机、双盲、安慰剂对照试验
J Infect. 2025 Jun 20;91(2):106539. doi: 10.1016/j.jinf.2025.106539.
9
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.幽门螺杆菌阳性人群消化性溃疡疾病的根除治疗。
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5.
10
Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes.运动诱发的应激行为、肠道微生物群-脑轴与饮食:运动员的系统综述。
J Int Soc Sports Nutr. 2016 Nov 24;13:43. doi: 10.1186/s12970-016-0155-6. eCollection 2016.

本文引用的文献

1
Pretreatment with BAA2573 ameliorates dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota.用BAA2573进行预处理可通过调节肠道微生物群来改善葡聚糖硫酸钠(DSS)诱导的结肠炎。
Front Microbiol. 2023 Jun 6;14:1211259. doi: 10.3389/fmicb.2023.1211259. eCollection 2023.
2
Infection and Peptic Ulcer Disease in Symptomatic Children in Southern Vietnam: A Prospective Multicenter Study.越南南部有症状儿童的感染与消化性溃疡疾病:一项前瞻性多中心研究
Healthcare (Basel). 2023 Jun 5;11(11):1658. doi: 10.3390/healthcare11111658.
3
The role of intestinal microbiota and microRNAs in the anti-inflammatory effects of cranberry: from pre-clinical to clinical studies.
肠道微生物群和微小RNA在蔓越莓抗炎作用中的作用:从临床前研究到临床研究
Front Nutr. 2023 May 23;10:1092342. doi: 10.3389/fnut.2023.1092342. eCollection 2023.
4
Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis.不同益生菌补充剂对三联幽门螺杆菌根除效果的比较:网络荟萃分析。
Front Cell Infect Microbiol. 2023 May 15;13:1120789. doi: 10.3389/fcimb.2023.1120789. eCollection 2023.
5
Novel Dietary Approach with Probiotics, Prebiotics, and Synbiotics to Mitigate Antimicrobial Resistance and Subsequent Out Marketplace of Antimicrobial Agents: A Review.采用益生菌、益生元及合生元的新型饮食方法减轻抗生素耐药性及后续抗菌药物退出市场:综述
Infect Drug Resist. 2023 May 23;16:3191-3211. doi: 10.2147/IDR.S413416. eCollection 2023.
6
Gastric microbiota: an emerging player in gastric cancer.胃微生物群:胃癌中一个新出现的因素
Front Microbiol. 2023 Apr 27;14:1130001. doi: 10.3389/fmicb.2023.1130001. eCollection 2023.
7
The Potential of Alternative Therapies and Vaccine Candidates against .替代疗法和候选疫苗对抗……的潜力
Pharmaceuticals (Basel). 2023 Apr 6;16(4):552. doi: 10.3390/ph16040552.
8
Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice.幽门螺杆菌的抗生素耐药性:从潜在的生物分子机制到临床实践。
J Clin Lab Anal. 2023 Apr;37(7):e24885. doi: 10.1002/jcla.24885. Epub 2023 Apr 23.
9
Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial.比较高剂量双联疗法与含铋四联疗法对海南岛幽门螺杆菌感染初次根除的疗效:一项随机、多中心临床试验。
Clin Res Hepatol Gastroenterol. 2023 May;47(5):102125. doi: 10.1016/j.clinre.2023.102125. Epub 2023 Apr 14.
10
Research progress of gut microbiota and obesity caused by high-fat diet.高脂肪饮食导致的肠道菌群与肥胖的研究进展。
Front Cell Infect Microbiol. 2023 Mar 13;13:1139800. doi: 10.3389/fcimb.2023.1139800. eCollection 2023.